Multiple Domains Are Required for the Toxic Activity of Pseudomonas aeruginosa ExoU

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Bacteriology

• Publication date

  2001-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JB.183.14.4330-4344.2001PMID 11418575PMCID PMC95324
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acquisition of Expression of the Pseudomonas aeruginosa ExoU Cytotoxin Leads to Increased Bacterial Virulence in a Murine Model of Acute Pneumonia and Systemic Spread

  2000cited by this paper
• Pseudomonas aeruginosa Cystic Fibrosis Isolates Induce Rapid, Type III Secretion-Dependent, but ExoU-Independent, Oncosis of Macrophages and Polymorphonuclear Neutrophils

  2000cited by this paper
• The amino‐terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small‐molecular‐weight GTP‐binding proteins

  1999cited by this paper
• Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury

  1999cited by this paper
• Identification of the Minimal Intracellular Vacuolating Domain of the Helicobacter pylori Vacuolating Toxin*

  1999cited by this paper
• Towards deciphering the Helicobacter pylori cytotoxin

  1999cited by this paper
• YopJ of Yersinia spp. Is Sufficient To Cause Downregulation of Multiple Mitogen-Activated Protein Kinases in Eukaryotic Cells

  1999cited by this paper
• The N-terminal Domain of Pseudomonas aeruginosaExoenzyme S Is a GTPase-activating Protein for Rho GTPases*

  1999cited by this paper
• ADP‐ribosylation of oncogenic Ras proteins by Pseudomonas aeruginosa exoenzyme S in vivo

  1999influential reference
• Pseudomonas aeruginosa Exoenzyme S, a Double ADP-ribosyltransferase, Resembles Vertebrate Mono-ADP-ribosyltransferases*

  1999cited by this paper
• Pseudomonas aeruginosa Induces Type-III-Secretion-Mediated Apoptosis of Macrophages and Epithelial Cells

  1999cited by this paper
• Biological Effects of Pseudomonas aeruginosa Type III-Secreted Proteins on CHO Cells

  1999cited by this paper
• Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia.

  1999cited by this paper
• Macrophages and Epithelial Cells Respond Differently to the Pseudomonas aeruginosa Type III Secretion System

  1999cited by this paper
• Regulation of ExoS Production and Secretion byPseudomonas aeruginosa in Response to Tissue Culture Conditions

  1999cited by this paper
• ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system.

  1998cited by this paper
• Identification and Characterization of SpcU, a Chaperone Required for Efficient Secretion of the ExoU Cytotoxin

  1998cited by this paper
• Modification of Ras in Eukaryotic Cells by Pseudomonas aeruginosa Exoenzyme S

  1998cited by this paper
• Identification of an amino‐terminal substrate‐binding domain in the Yersinia tyrosine phosphatase that is required for efficient recognition of focal adhesion targets

  1998cited by this paper
• The Salmonella typhimurium tyrosine phosphatase SptP is translocated into host cells and disrupts the actin cytoskeleton

  1998cited by this paper
• PepA, a secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence

  1998influential reference
• A complex composed of SycN and YscB functions as a specific chaperone for YopN in Yersinia pestis

  1998cited by this paper
• Pseudomonas aeruginosa Exoenzyme S ADP-ribosylates Ras at Multiple Sites*

  1998cited by this paper
• Intracellular expression of the ADP‐ribosyltransferase domain of Pseudomonas exoenzyme S is cytotoxic to eukaryotic cells

  1998cited by this paper
• In Vitro Cellular Toxicity PredictsPseudomonas aeruginosa Virulence in Lung Infections

  1998cited by this paper
• Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S

  1997cited by this paper
• ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury

  1997cited by this paper
• Acid-induced Dissociation of VacA, the Helicobacter pylori Vacuolating Cytotoxin, Reveals Its Pattern of Assembly

  1997cited by this paper
• Identification of type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulon

  1997cited by this paper
• Identification of Pseudomonas aeruginosa genes required for epithelial cell injury

  1997cited by this paper
• The exoenzyme S regulon of Pseudomonas aeruginosa

  1997cited by this paper
• Identification of a promoter-specific transactivation domain in the herpes simplex virus regulatory protein ICP4

  1997cited by this paper
• Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway

  1996cited by this paper
• Pertussis toxin-mediated ADP-ribosylation of target proteins in Chinese hamster ovary cells involves a vesicle trafficking mechanism

  1995cited by this paper
• Expression of recombinant exoenzyme S of Pseudomonas aeruginosa

  1995cited by this paper
• Functional domains of Pseudomonas aeruginosa exoenzyme S

  1995cited by this paper
• Identification of the YopE and YopH domains required for secretion and internalization into the cytosol of macrophages, using the cyaA gene fusion approach.

  1995cited by this paper
• Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing

  1995cited by this paper
• Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury.

  1994cited by this paper
• Construction and characterization of chromosomal insertional mutations of the Pseudomonas aeruginosa exoenzyme S trans-regulatory locus

  1994cited by this paper
• Purification and characterization of exoenzyme S from Pseudomonas aeruginosa 388

  1993cited by this paper
• The eukaryotic host factor that activates exoenzyme S of Pseudomonas aeruginosa is a member of the 14-3-3 protein family.

  1993cited by this paper

• Molecular investigation of exoU and exoY virulence genes in Pseudomonas aeruginosa collected from hospitalized patients in North of Iran: A descriptive-analytical study

  2024cites this paper
• Unveiling the ocular battlefield: Insights into Pseudomonas aeruginosa virulence factors and their implications for multidrug resistance.

  2024cites this paper
• Active immunization with Pseudomonas aeruginosa vaccine protects mice from secondary Pseudomonas aeruginosa challenge post-influenza virus infection

  2023cites this paper
• ExoU Induces Lung Endothelial Cell Damage and Activates Pro-Inflammatory Caspase-1 during Pseudomonas aeruginosa Infection

  2022cites this paper
• CrkII/Abl phosphorylation cascade is critical for NLRC4 inflammasome activity and is blocked by Pseudomonas aeruginosa ExoT

  2022cites this paper
• Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics

  2022cites this paper
• CrkII/Abl phosphorylation cascade is critical for NLRC4 inflammasome activity and is blocked by Pseudomonas aeruginosa ExoT

  2022cites this paper
• The Pseudomonas aeruginosa Type III Secretion System Exoenzyme Effector ExoU Induces Mitochondrial Damage in a Murine Bone Marrow-Derived Macrophage Infection Model

  2022cites this paper
• Perspectives on the Pseudomonas aeruginosa Type III Secretion System Effector ExoU and Its Subversion of the Host Innate Immune Response to Infection

  2021cites this paper
• Utilizing in silico and in vitro methods to identify possible binding sites of a novel ligand against Pseudomonas aeruginosa phospholipase toxin ExoU

  2021cites this paper
• Pseudomonas aeruginosa Toxin ExoU as a Therapeutic Target in the Treatment of Bacterial Infections

  2019cites this paper
• Identification and Verification of Ubiquitin-Activated Bacterial Phospholipases

  2018cites this paper
• Phosphatidylinositol 4,5-Bisphosphate-Dependent Oligomerization of the Pseudomonas aeruginosa Cytotoxin ExoU

  2017cites this paper
• Explorer Effector ExoU from the type III secretion system is an important modulator of gene expression in lung epithelial cells in response to Pseudomonas aeruginosa infection

  2017cites this paper
• Presence of exoY, exoS, exoU and exoT genes, antibiotic resistance and biofilm production among Pseudomonas aeruginosa isolates in Northwest Iran

  2016cites this paper
• Pseudomonas aeruginosa toxins

  2015cites this paper
• Ubiquitin Activates Patatin-Like Phospholipases from Multiple Bacterial Species

  2014cites this paper
• Structural basis for the recruitment and activation of the Legionella phospholipase VipD by the host GTPase Rab5

  2014cites this paper
• Intoxication of Host Cells by the T3SS Phospholipase ExoU: PI(4,5)P2-Associated, Cytoskeletal Collapse and Late Phase Membrane Blebbing

  2014cites this paper
• In vitro assays to monitor the activity of Pseudomonas aeruginosa Type III secreted proteins.

  2014cites this paper
• Phospholipase A2 Activity Exhibited by a Bacterial Virulence Protein That Enters and Operates Within a Variety of Host Cells

  2014cites this paper
• Immune surveillance mechanisms of the skin against the stealth infection strategy of Pseudomonas aeruginosa-review.

  2013cites this paper
• Structure of the Type III Secretion Effector Protein ExoU in Complex with Its Chaperone SpcU

  2012influential citation
• Structural Basis of Cytotoxicity Mediated by the Type III Secretion Toxin ExoU from Pseudomonas aeruginosa

  2012cites this paper
• Diversity of Antimicrobial Resistance and Virulence Determinants in Pseudomonas aeruginosa Associated with Fresh Vegetables

  2012cites this paper
• Ubiquitin and ubiquitin‐modified proteins activate the Pseudomonas aeruginosa T3SS cytotoxin, ExoU

  2011cites this paper
• The unexpected link between infection‐induced apoptosis and a Th17 immune response

  2011cites this paper
• The Rickettsia prowazekii ExoU Homologue Possesses Phospholipase A1 (PLA1), PLA2, and Lyso-PLA2 Activities and Can Function in the Absence of Any Eukaryotic Cofactors In Vitro

  2011cites this paper
• Apoptosis and TH17 Cell Differentiation

  2011cites this paper
• Induced conformational changes in the activation of the Pseudomonas aeruginosa type III toxin, ExoU.

  2011cites this paper
• Truncation of more than nine amino acid residues from the C-terminus of ExoU dramatically abrogates

  2011cites this paper
• Activation of ExoU Phospholipase Activity Requires Specific C-Terminal Regions (cid:1)

  2010cites this paper
• Role of the Membrane Localization Domain of the Pseudomonas aeruginosa Effector Protein ExoU in Cytotoxicity

  2010cites this paper
• Pseudomonas aeruginosa Cytotoxin ExoU Is Injected into Phagocytic Cells during Acute Pneumonia

  2010cites this paper
• Activation of ExoU Phospholipase Activity Requires Specific C-Terminal Regions

  2010cites this paper
• The type III secretion system of Pseudomonas aeruginosa: infection by injection

  2009cites this paper
• Charakterisierung Patatin-ähnlicher Proteine des Lungenpathogens Legionella pneumophila

  2009influential citation
• Identification of Small Molecule Inhibitors of Pseudomonas aeruginosa Exoenzyme S Using a Yeast Phenotypic Screen

  2008cites this paper
• Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia.

  2008cites this paper
• An Engineered Human Antibody Fab Fragment Specific for Pseudomonas aeruginosa PcrV Antigen Has Potent Antibacterial Activity

  2008cites this paper
• Pseudomonas aeruginosa Induces Localized Immunosuppression during Pneumonia

  2007cites this paper
• Type III Secretory Proteins in Pseudomonas aeruginosa

  2007cites this paper
• Mutation of the phospholipase catalytic domain of the Pseudomonas aeruginosa cytotoxin ExoU abolishes colonization promoting activity and reduces corneal disease severity.

  2007cites this paper
• Type III Secretion Systems and Disease

  2007cites this paper
• Interactions between effector proteins of the Pseudomonas aeruginosa type III secretion system do not significantly affect several measures of disease severity in mammals.

  2006cites this paper
• CHAPTER 14 – Pseudomonas aeruginosa toxins

  2006cites this paper
• A C-Terminal Domain Targets the Pseudomonas aeruginosa Cytotoxin ExoU to the Plasma Membrane of Host Cells

  2006influential citation
• Identification of superoxide dismutase as a cofactor for the pseudomonas type III toxin, ExoU.

  2006cites this paper
• Pathogen-host interactions in Pseudomonas aeruginosa pneumonia.

  2005cites this paper
• State of the Art Pathogen–Host Interactions in Pseudomonas aeruginosa Pneumonia

  2005cites this paper
• Mechanisms of action of the Pseudomonas aeruginosa type III secreted toxins

  2005influential citation
• Functional Regions of the Pseudomonas aeruginosa Cytotoxin ExoU

  2005influential citation
• Virulence Factors in Pseudomonas Aeruginosa

  2004cites this paper
• Lysophospholipase A activity of Pseudomonas aeruginosa type III secretory toxin ExoU.

  2004cites this paper
• Effect of Metabolic Imbalance on Expression of Type III Secretion Genes in Pseudomonas aeruginosa

  2004cites this paper
• Ezrin/Radixin/Moesin Proteins Are High Affinity Targets for ADP-ribosylation by Pseudomonas aeruginosa ExoS*

  2004cites this paper
• ExoU: A cytotoxin delivered by the type III secretion system of Pseudomonas aeruginosa

  2004influential citation
• Charakterisierung von zytotoxischen Pseudomonas aeruginosa "small colony variants" isoliert aus dem Respirationstrakt von Patienten mit Cystischer Fibrose

  2004cites this paper
• Patatin-like proteins: a new family of lipolytic enzymes present in bacteria?

  2004cites this paper
• ExoU is a potent intracellular phospholipase

  2004cites this paper
• Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia.

  2003cites this paper
• Molecular Pathogenesis of Acute Pseudomonas Aeruginosa Infections

  2003cites this paper
• Effector ExoU from the Type III Secretion System Is an Important Modulator of Gene Expression in Lung Epithelial Cells in Response to Pseudomonas aeruginosa Infection

  2003cites this paper
• Pseudomonas aeruginosa ExoU, a Toxin Transported by the Type III Secretion System, Kills Saccharomyces cerevisiae

  2003cites this paper
• Apoptotic Response of Chang Cells to Infection with Pseudomonas aeruginosa Strains PAK and PAO-I: Molecular Ordering of the Apoptosis Signaling Cascade and Role of Type IV Pili

  2003cites this paper
• The mechanism of action of the Pseudomonas aeruginosa‐encoded type III cytotoxin, ExoU

  2003cites this paper
• Infection Pseudomonas aeruginosa Response to Expression in Lung Epithelial Cells in System Is an Important Modulator of Gene Effector ExoU from the Type III Secretion

  2003cites this paper
• Contribution of ExsA-regulated factors to corneal infection by cytotoxic and invasive Pseudomonas aeruginosa in a murine scarification model.

  2003cites this paper
• In Vivo Phospholipase Activity of the Pseudomonas aeruginosa Cytotoxin ExoU and Protection of Mammalian Cells with Phospholipase A2 Inhibitors*

  2003cites this paper
• Mutation of csk, encoding the C-terminal Src kinase, reduces Pseudomonas aeruginosa internalization by mammalian cells and enhances bacterial cytotoxicity.

  2002cites this paper
• The multitalented pore-forming proteins of intracellular pathogens.

  2002cites this paper
• Exoenzyme S shows selective ADP-ribosylation and GTPase-activating protein (GAP) activities towards small GTPases in vivo.

  2002cites this paper